A basic background on the prostate gland, prostate cancer, mode of action of LHRHa drugs, a review some of our clinical data and case studies and a demonstration of the injection implant.
As prostate cancer is increasingly managed by HCPs in primary care, it is important to refresh and update clinical knowledge to improve outcomes for patients.
For any Cancer Specialist Nurses / Nurse Team and any other HCPs who are caring for prostate cancer patients to discuss how best we can collaborate to achieve those aims.
This virtual session will also include device demonstrations for the implant and a refresher for differentiating product evidence.
This training is being provided and delivered by Astrazeneca. Your contact details will be shared with them.
